期刊文献+

沉默Stat3对卵巢癌细胞系OV2008恶性表型的影响

Effects of Blocking Stat3 on the Malignant Phenotype of Ovarian Cancer Cell Line OV2008
下载PDF
导出
摘要 目的:探讨沉默信号转导和转录活化因子(Stat3)对卵巢癌细胞系OV2008恶性表型的影响。方法:腺病毒M4感染卵巢癌细胞系OV2008后,利用RT-PCR法检测Sta t3 mRNA的表达水平;Western blot法检测Stat3蛋白的表达水平;MTT法检测沉默Stat3对OV2008细胞的增殖抑制的影响;Transwell小室法检测沉默Stat3对OV2008细胞的侵袭运动能力的影响;流式细胞术检测沉默Stat3对OV2008细胞的凋亡的影响结果:RT-PCR以及Westetn blot结果显示,腺病毒M4感染卵巢癌细胞系OV2008后,OV2008细胞中的Sta3t mRNA以及Stat3蛋白的表达水平均明显降低;MTT结果显示,沉默Stat3表达后的OV2008细胞与空白对照组以及Ad5/dE1A病毒对照组的细胞相比,增殖能力明显减弱(P<0.05);Transwell小室法结果显示,沉默Stat3后的OV2008细胞12.64±7.10与空白对照组127.70±8.28以及Ad5/dElA病毒对照组137.80±9.78相比,侵袭运动能力明显减弱(P<0.05);流式细胞术检测结果显示,沉默Stat3表达后的OV2008细胞65.51±5.78与空白对照组10.73±4.28以及Ad5/dElA病毒对照组12.17±3.87相比,细胞凋亡率明显增加(P<0.05)。结论:沉默Stat3能明显抑制卵巢癌细胞系OV2008的增殖,降低其侵袭运动能力,并诱导其凋亡,即沉默Stat3能降低卵巢癌细胞系OV2008的恶性表型,提示Stat3可作为卵巢癌基因治疗的一个新的分子靶点。 Objective: To investigate the effects of blocking the signal transducer and activator of transcription 3 ( Stat3 ) on the malignant phenotype of ovarian cancer cell line OV2008. Methods: An ovarian cancer cell line OV2008 sample was infected with adenovirus M4. Reverse transcriptase polymerase chain reaction and Western blot assays were used to detect the Stat3 mRNA and protein levels, respectively. The effects of blocking Stat3 on cell proliferation, apoptotic rate, and cell invasion capacity were determined by MTT analysis, flow cytometry, and transwell migration assay, respectively. Results: The Stat3 mRNA and protein levels both notice- ably decreased in M4-infected OV2008 cells. The proliferation rates of the Stat3-blocked OV2008 cells were significantly slower than those of the control and Ad5/dE1A-infected groups ( P〈 0.05 ). The invasion capacity of the Stat3-blocked OV2008 cells was ( 12.64 ± 9.1 ). This value was much lower than those of the control ( 127.7 ±8.28 ) and Ad5/dE1A-infected groups ( 137.8 ± 9.78 ) ( P 〈 0.05 ). The apoptosis rate of Stat3-blocked OV2008 cells was ( 65.51 ± 5.78 ). This value was significantly higher than those of the control ( 10.73 ± 4.28 ) and Ad5/dE1A-infected groups ( 12.17 ± 3.87 ) ( P 〈 0.05 ). Conclusion: Stat3 blockage led to decreased proliferation, increased apoptosis, and decreased invasion capacity in OV2008 cells. Hence, Stat3 may be a new target for ovarian cancer gene therapy.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第16期935-937,946,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金青年科学基金项目(编号:30801224)资助~~
关键词 卵巢癌 STAT3 增殖 侵袭 Ovarian cancer Stat3 Proliferation Invasion
  • 相关文献

参考文献3

二级参考文献170

  • 1张真发,马建群,孙楠,张林.非小细胞肺癌中STAT3与MAPK的表达及临床意义[J].中国肿瘤临床,2004,31(20):1167-1170. 被引量:5
  • 2俞丽芬,朱延波,乔敏敏,钟捷,涂水平,吴云林.Stat3在人胃癌细胞株和组织中的组成性激活及其临床意义[J].中华医学杂志,2004,84(24):2064-2069. 被引量:29
  • 3李玲,陈刚,林安.子宫内膜癌中P16^(INK4a)和CyclinD1基因的表达及临床意义[J].福建医药杂志,2005,27(2):110-112. 被引量:3
  • 4Grandis JR, Drenning SD, Chakraborty A, et al. Requirement of Stat3 but not Statl activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest 1998, 102:1385 - 1392.
  • 5Grandis JR, Drenning SD, Zeng Q, et al. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcino-genesis in vivo. Proc Natl Acad Sci USA 2000, 97:4227-4232.
  • 6Becker S, Groner B, Muller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998,394:145- 151.
  • 7Gray M J, Zhang J, Ellis LM, et al. HIF- 1 alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005, 24:3110- 3120.
  • 8Loeffler S, Fayard B, Weis J, Weissenberger J. Intedeukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Spl. IntJ Cancer 2005,115:202-213.
  • 9Albanell J, Rojo F, Baselga J. Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839. Semin Oncol 2001, 28:56-66.
  • 10Han SW, Hwang PG, Chung DH, et al. Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD 1839) in chemotherapy-resistant non-small cell lung cancer. Int J Cancer 2005,113:109-115.

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部